Patient-relevant treatment goals in psoriasis
- 19 December 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv für dermatologische Forschung
- Vol. 308 (2), 69-78
- https://doi.org/10.1007/s00403-015-1613-8
Abstract
Patient-oriented care requires therapeutic decisions to agree with the patients’ treatment needs and goals. This study addressed the following questions: What is important to psoriasis patients starting systemic treatment? How stable are these preferences within the first year of treatment? Are treatment goals associated with age, gender, or treatment success? The importance of treatment goals was assessed for patients with moderate-to-severe psoriasis in the German Psoriasis Registry (PsoBest) at baseline (onset of a systemic treatment; n = 3066) and at a 1-year follow-up (n = 1444) using the Patient Benefit Index (PBI). Treatment success was measured with PBI global score and Psoriasis Area Severity Index (PASI). Patients with moderate-to-severe psoriasis pursued a wide range of different goals. The most general treatment goals were rated most relevant, including skin healing and quick skin improvement (94.8/94.5 % “quite” or “very” important), confidence in the therapy (93.0 %), control over the disease (92.3 %), and a clear diagnosis and therapy (89.6 %). Further important goals related to not being in fear of the disease getting worse (84.8 %), reduction in itching (83.9 %), burning (70.6 %), and pain (60.6 %) as well as attaining a normal everyday life (78.4 %) and low treatment burden (64.2–77.9 %). Goals were mostly not associated with sex and gender. Goal importance slightly increased with treatment success. In a substantial proportion of patients (30.3–54.7 %) goal importance changed within 1 year after onset of systemic treatment. We conclude that treatment goal importance should be assessed in clinical practice on a regular basis.Keywords
Funding Information
- German Federal Ministry of Education and Research (BMBF) (01EH1101B, 01EH1101B)
This publication has 19 references indexed in Scilit:
- Patient-relevant needs and treatment goals in nail psoriasisQuality of Life Research, 2015
- A 10-year trend of insomnia prevalence in the adult Norwegian populationSleep Medicine, 2014
- Burden of Disease: Psoriasis and Psoriatic ArthritisAmerican Journal of Clinical Dermatology, 2013
- Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasisArchiv für dermatologische Forschung, 2012
- German S3-guidelines on the treatment of psoriasis vulgaris (short version)Archiv für dermatologische Forschung, 2012
- Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare RegistryJournal of the European Academy of Dermatology and Venereology, 2012
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusionsJournal of the American Academy of Dermatology, 2011
- The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseasesArchiv für dermatologische Forschung, 2009
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJournal of the American Academy of Dermatology, 2008
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978